Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Sanofi Genzyme

- PMLiVE

Alnylam pulls lead drug revusiran after deaths in phase III trial

US biotech has yet to determine the cause of the amyloidosis and cardiomyopathy study fatalities

- PMLiVE

Lucid adds to senior leadership team

Shula Sarner and Tanya Goodyear join the med comms agency

- PMLiVE

Who’s listening? Why a tailored approach to education improves outcomes

In an increasingly resource-constrained environment with a growing need to show measurable impact in patient outcomes, medical education needs to smarten up. A blanket approach is no longer enough: we...

- PMLiVE

Making a difference with medical education

Curiosity drives us, tenacity allows us to rise and creativity enables us to shine

- PMLiVE

Sanofi Genzyme launches multiple sclerosis awareness campaign

Aims to highlight and address the physical and emotional burden of the disease

- PMLiVE

Celebrating excellence

Recognising excellence in improving patient outcomes

Digital roundup

Genzyme, Merck, the forthcoming EU clinical trials portal and more

Lucid group celebrate their outstanding year in style at The Shard

A fabulous montage from our end of year meeting at The Shard. Celebrating our achievements the Lucid way.

Lucid Group Communications Limited

- PMLiVE

Quintiles wins New Models of Care award at PMEA

Rewarded for its rheumatology project for Pfizer

- PMLiVE

Blue Latitude’s industry-first praised at PMEA

Support for Lilly and its Medical Information Cascade wins Innovation Award

- PMLiVE

Lucid behavioural change programmes recognised at PMEA

Agency wins awards for initiatives for AbbVieand Genzyme

- PMLiVE

PMEA 2015 win for Novo’s Changing Diabetes in Children

Company wins the EY Award for SociallyResponsible Initiatives

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links